Genus Plc Stock Price, News & Analysis
Company Description
Genus Plc (OTC Link: GENSY) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $2.0B.
GENSY stock has gained 49.6% over the past year. Shares last traded at $34.41.
This page provides a comprehensive overview of GENSY stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Genus Plc (GENSY) stock last traded at $34.41. Over the past 12 months, the stock has gained 49.6%. At a market capitalization of $2.0B, GENSY is classified as a small-cap stock with approximately 66.5M shares outstanding.
Latest News
Genus Plc has 5 recent news articles. Key topics include acquisition, AI. View all GENSY news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Genus Plc (GENSY) currently stands at 179 shares, down 2.2% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has increased by 79%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Genus Plc (GENSY) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 64% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
GENSY Company Profile & Sector Positioning
Genus Plc (GENSY) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing GENSY often look at related companies in the same sector, including Northwest Bio (NWBO), Cytodyn Inc (CYDY), Clinuvl Phrmaceu (CLVLY), Nuo Therapeutics (AURX), and Alk-Abello A/S (AKBLF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate GENSY's relative position within its industry.